Lombard Odier Asset Management (Switzerland) Sa Invitae Corp Transaction History

Lombard Odier Asset Management (Switzerland) Sa

$1.4 Billion
Q1 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.9 - $8.63 $848,933 - $3.86 Million	-446,807 Reduced 73.6%	160,254 $394,000
Q2 2022 Aug 15, 2022	SELL	$2.13 - $9.01 $512,827 - $2.17 Million	-240,764 Reduced 28.4%	607,061 $1.48 Million
Q1 2022 May 16, 2022	BUY	$6.28 - $15.59 $360,654 - $895,318	57,429 Added 7.27%	847,825 $6.76 Million
Q4 2021 Feb 14, 2022	BUY	$14.7 - $28.67 $982,753 - $1.92 Million	66,854 Added 9.24%	790,396 $12.1 Million
Q3 2021 Nov 12, 2021	BUY	$24.31 - $33.6 $1.64 Million - $2.26 Million	67,405 Added 10.27%	723,542 $20.6 Million

Q2 2021 Aug 13, 2021	BUY	$26.09 - $40.4 $9.2 Million - $14.2 Million	352,541 Added 116.12%	656,137 $22.1 Million
Q1 2021 May 17, 2021	BUY	$33.06 - $56.93 $10 Million - $17.3 Million	303,596 New	303,596 $11.6 Million

Others Institutions Holding NVTA

# of Institutions

Shares Held

7.66M

Call Options Held

Put Options Held

View Full List

About Invitae Corp

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

More about NVTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Switzerland) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Switzerland) Sa with notifications on news.

Account